This often appears on a background of endometrial hyperplasia.

Raloxifene did not increase the risk of endometrial hyperplasia.

This process is associated with an increased incidence of endometrial hyperplasia and carcinoma.

As such dydrogesterone effectively guards against the development of endometrial hyperplasia.

You can take birth control pills or other hormone medicines to reduce the risk of endometrial hyperplasia.

Testing for endometrial cancer may show that you have endometrial hyperplasia.

If endometrial hyperplasia is not treated, it may progress to endometrial cancer.

Taking tamoxifen, a breast cancer treatment that acts like estrogen in the uterus.3 Having endometrial hyperplasia.

Endometrial sampling also identified 14 additional cases of endometrial hyperplasia.

Excessive growth of the lining of the uterus (endometrial hyperplasia).

However, endometrial hyperplasia should never be ignored since it can become a premalignant and ultimately a cancerous condition.

Another reason for hysterectomy is endometrial hyperplasia, an overgrowth of the tissue lining the uterus.

Estradiol may increase your risk of developing endometrial hyperplasia, a condition that can lead to cancer of the uterus.

This is called endometrial hyperplasia.

May prevent endometrial hyperplasia or endometrial cancer.

Endometrial hyperplasia.

Abnormal growth of cells in the uterus' lining - called the endometrium - is called endometrial hyperplasia.

Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone.

However, A high prevalence of endometrial hyperplasia has been noted in a small study of transgender men undergoing hysterectomy.

Longstanding anovulation can also lead to endometrial hyperplasia and facilitate the development of endometrial cancer.

The two compounds do not differentiate in their ability to suppress endometrial hyperplasia, nor does either increase the risk of pulmonary embolism.

Detection by ultrasonography can be difficult, particularly when there is endometrial hyperplasia (excessive thickening of the endometrium).

Medroxyprogesterone is also used to decrease the risk of endometrial hyperplasia (a condition that may lead to uterine cancer) while taking estrogens.

Preventing or reducing abnormal thickening of the lining of the uterus (endometrial hyperplasia).

(Endometrial hyperplasia, which may develop into endometrial cancer, is one cause of abnormal bleeding.)